The public values practical benefits above science superpower status, say Ben Bleasdale and Daniel Rathbone
Across the country, people are seeing an increase in the cost of living, as memories of the UK’s vaccine triumph fade. Against this backdrop, those calling for greater investment in R&D risk looking out of touch with reality and their sector becoming a target for cuts rather than commitments.
Unless we land our message with due sensitivity, grand ambitions for R&D will come up against an increasingly simple question—what’s the point? At the Campaign for Science and Engineering, we heard this first-hand back in May during our public focus groups in Manchester.